Related Experiment Video
Updated: Jul 15, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
The adverse effects of antiepileptic drugs in children
Sanjeev V Kothare1, Joseph Kaleyias
1St Christopher's Hospital for Children, Section of Neurology, Department of Pediatrics, Drexel University College of Medicine, Philadelphia, PA 19134, USA. skothare@drexelmed.edu
Insights
Antiepileptic drugs (AEDs) have similar efficacy, making adverse effects (AEs) crucial for selection. This review details neurocognitive, developmental, and other AEs, emphasizing pediatric and pregnancy risks.
Area of Science:
- Pharmacology
- Neurology
- Teratology
Background:
- Antiepileptic drugs (AEDs) exhibit comparable efficacy, necessitating adverse effect (AE) evaluation for treatment selection.
- Neurocognitive AEs are common with AED use, particularly in high-risk populations.
- Concerns extend beyond first-trimester teratogenesis to potential neurocognitive developmental delays in later pregnancy.
Purpose of the Study:
- To review and classify adverse effects of antiepileptic drugs (AEDs).
- To highlight age-specific AEs, with a focus on pediatric populations.
- To discuss the impact of AEDs on various physiological functions.
Main Methods:
- Literature review of antiepileptic drug adverse effects.
- Analysis of neurocognitive, teratogenic, and other physiological impacts.
- Classification of adverse effects based on various parameters.
Main Results:
- Neurocognitive adverse effects are nearly inevitable with AED use.
- Potential for neurocognitive developmental delay exists with AED use throughout pregnancy.
- AEDs are associated with decreased bone mineral density, altered lipid profiles, weight changes, and endocrine/reproductive dysfunction.
- Age-specific AEs, particularly in pediatric populations, are influenced by pharmacokinetic differences.
Conclusions:
- Adverse effects, including neurocognitive and developmental issues, are critical considerations in AED selection.
- Comprehensive understanding of AED AEs is vital for all patient populations, especially pregnant women and children.
- A structured classification of AED AEs aids in clinical management and research.
Abstract:
Efficacy of antiepileptic drugs (AEDs) are often equivalent, hence selection of an AED is often determined by the adverse effects (AEs). The development of neurocognitive AEs is almost inevitable with use of AEDs, especially in high-risk groups. Teratogenesis with major or minor malformations is of great concern during the first trimester of pregnancy, but an increasing body of information suggests that potential neurocognitive developmental delay may also occur with use of AEDs in the latter part of pregnancy. Decreased bone mineral density has been found in adults and children receiving both enzyme-inducing AEDs and valproate, an enzyme-inhibiting drug. AEDs may influence the lipid profile, body weight, reproductive, hormonal and other endocrine functions, and sleep architecture. There are age-specific AEs related to pharmacokinetic differences that have been highlighted in this review with emphasis on the pediatric population. A classification of AEs using different parameters is also included.
Related Concept Videos
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...

